Home

Latest News

12345678910
TOST Q1 Earnings Call: Revenue Misses Estimates, Margin Expansion and Enterprise Growth Highlighted
Restaurant software platform Toast (NYSE:TOST) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 24.4% year on year to $1.34 billion. Its non-GAAP profit of $0.24 per share was 30.1% above analysts’ consensus estimates.
Via StockStory · May 9, 2025
CMB.TECH CEO Speaks On Shifting Investor Focus From Asset Values To Sustainable Earnings Powerbenzinga.com
Via Benzinga · May 9, 2025
What's Going On With Lucid Shares Today?benzinga.com
Via Benzinga · May 9, 2025
This Week In Cannabis: Earnings Divide The Market As DEA, Brands And Bills Move Forwardbenzinga.com
This week: Q1 earnings reveal a widening market divide, DEA nominee prioritizes rescheduling, and Rove and Swade make big expansion plays.
Via Benzinga · May 9, 2025
Earnings Preview: Solo Brandsbenzinga.com
Via Benzinga · May 9, 2025
Insights into Ispire Technology's Upcoming Earningsbenzinga.com
Via Benzinga · May 9, 2025
An Overview of Village Farms Intl's Earningsbenzinga.com
Via Benzinga · May 9, 2025
D-Wave's Quantum Momentum Impresses Analyst, Sees Stronger Commercial Uptake Aheadbenzinga.com
D-Wave shares rose after an analyst praised its revenue surge, high-margin system sales, and growing commercial traction in quantum solutions.
Via Benzinga · May 9, 2025
80 Percent Tariff On China ‘Seems Right’ Says Trump, But It’s Nearly As Stupidtalkmarkets.com
An 80 percent tariff is nearly as stupid as a 145 percent tariff because most trade with China would still stop. Trade might stop at 50 percent.
Via Talk Markets · May 9, 2025
YETI Q1 Earnings Call: Supply Chain Shifts and Tariff Pressures Lead to Lower Profit Outlook
Outdoor lifestyle products brand (NYSE:YETI) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 2.9% year on year to $351.1 million. Its non-GAAP profit of $0.31 per share was 14.6% above analysts’ consensus estimates.
Via StockStory · May 9, 2025
Trump Appointed Martin Makary Targets Faster Drug Approvals With FDA Artificial Intelligence Overhaulbenzinga.com
FDA will implement a secure generative AI system across all centers by June 30, aiming to streamline internal reviews and modernize drug approvals.
Via Benzinga · May 9, 2025
Earnings Outlook For Blade Air Mobilitybenzinga.com
Via Benzinga · May 9, 2025
An Overview of Plug Power's Earningsbenzinga.com
Via Benzinga · May 9, 2025
Price Over Earnings Overview: Hamilton Lanebenzinga.com
Via Benzinga · May 9, 2025
Uncovering Potential: Aquestive Therapeutics's Earnings Previewbenzinga.com
Via Benzinga · May 9, 2025
Trump's HHS Overhaul Faces Legal Blowback From States Over Deep Staffing Cuts, Slashed Programsbenzinga.com
States are suing the federal government after HHS Secretary Robert F. Kennedy Jr. ordered layoffs and agency closures, disrupting critical public health programs nationwide.
Via Benzinga · May 9, 2025
Birkenstock Has A Tariff Advantage Going In Q2: Analystbenzinga.com
Birkenstock earns praise from analyst for tariff resilience and strong Q2 growth outlook driven by premium positioning and solid global demand.
Via Benzinga · May 9, 2025
What Analysts Are Saying About Rocket Companies Stockbenzinga.com
Via Benzinga · May 9, 2025
Celsius Founder Gets 12 Years In Prison For Misleading Investors – Ordered to Pay $48Mstocktwits.com
Celsius Founder Alex Mashinsky had requested a one-year and one-day term, expressing remorse and a desire to make amends to his family and customers.
Via Stocktwits · May 9, 2025
Looking Into Keurig Dr Pepper's Recent Short Interestbenzinga.com
Via Benzinga · May 9, 2025
How Is The Market Feeling About Shift4 Payments?benzinga.com
Via Benzinga · May 9, 2025
QQQI: An Award-Winning Income Strategybenzinga.com
Via Benzinga · May 9, 2025
Demystifying NCR Voyix: Insights From 4 Analyst Reviewsbenzinga.com
Via Benzinga · May 9, 2025
What Analysts Are Saying About Shoals Technologies Gr Stockbenzinga.com
Via Benzinga · May 9, 2025
Demystifying Ouster: Insights From 4 Analyst Reviewsbenzinga.com
Via Benzinga · May 9, 2025
Assessing Invitation Homes: Insights From 10 Financial Analystsbenzinga.com
Via Benzinga · May 9, 2025
Demystifying CVRx: Insights From 4 Analyst Reviewsbenzinga.com
Via Benzinga · May 9, 2025
Is the Market Bullish or Bearish on Yum China Holdings?benzinga.com
Via Benzinga · May 9, 2025
Why Globalstar (GSAT) Stock Is Trading Lowerbenzinga.com
Globalstar shares are trading lower by 13.1% during Friday's session. The company reported worse-than-expected Q1 EPS and revenue.
Via Benzinga · May 9, 2025
President Trump Just Told Us What’s Comingtalkmarkets.com
All it took was two weeks of stocks falling to trigger a consumer panic that would have easily resulted in a recession had things not changed course.
Via Talk Markets · May 9, 2025
XRP Spikes 5% As Whales Scoop Up 880M Tokens In A Month: What Is Going On?benzinga.com
XRP (CRYPTO: XRP) is surging as fresh whale accumulation and positive sentiment around the SEC settlement spark renewed interest in the token.
Via Benzinga · May 9, 2025
Unfavorable Sports Outcomes Have Negatively Affected DraftKings' Outlook: Analystbenzinga.com
Needham analyst Bernie McTernan maintained a Buy rating on DraftKings Inc. (NASDAQ:DKNG) and reiterated the $65 price forecast following the first quarter results reported on Thursday.
Via Benzinga · May 9, 2025
ANI Pharma Reports Upbeat Q1 Earnings, Revises Full-Year Outlook: Retail’s Pleasedstocktwits.com
The CEO dismissed the impact of Trump tariffs, noting that the company produces a major portion of its goods in the U.S.
Via Stocktwits · May 9, 2025
Why Fox Factory Stock Was Climbing Todayfool.com
Via The Motley Fool · May 9, 2025
Coach Captures Gen Z Wallets, Drives Tapestry's EPS Upgrade, Says Analystbenzinga.com
Via Benzinga · May 9, 2025
Deal Or No Deal – Tariffs Useful Economic Tool. The Corn & Ethanol Reportcontent/com
U.S. corn export sales week ending May 1st totaled 65 Mil Bu, a full 57 Mil above the pace needed to meet USDA's annual forecast.
Via Talk Markets · May 9, 2025
Are You Missing Out on These 2 Dividend Raises From Tech Sector Powerhouses?fool.com
Via The Motley Fool · May 9, 2025
Stocks Slip As Gold Rebounds To $3,330, Bitcoin Holds $102,000: What's Driving Markets Friday?benzinga.com
Wall Street traded slightly lower by midday Friday, as investors adopted a wait-and-see stance ahead of a potential trade breakthrough, with high-stakes negotiations between U.S. officials—led by Treasury Secretary Scott Bessent—and Chinese authorities set to unfold over the weekend.
Via Benzinga · May 9, 2025
What's Going On With EchoStar Stock Friday?benzinga.com
EchoStar Corporation (NASDAQ: SATS) reported a loss of 71 cents per share, with quarterly sales of $3.87 billion. SATS stock has gained 56% in the past year.
Via Benzinga · May 9, 2025
Hopium Buying - India Ready To Cut Tariffs to 4%, Trump Floats China Tariffs At 80%, UK Not A Modelbenzinga.com
Via Benzinga · May 9, 2025
Stock Analysis: U.S. Bancorptalkmarkets.com
U.S. Bancorp is one of the largest regional banks in the US with its footprint in 26 states and assets of around $680 billion.
Via Talk Markets · May 9, 2025
Why TaskUs Stock Soared on Fridayfool.com
Via The Motley Fool · May 9, 2025
The Invisible Hand Of President Trump - The Energy Reportcontent/com
​​​​​​​The oil market is starting to finally turn around as President Trump’s trade deals may start to come fast and furious.
Via Talk Markets · May 9, 2025
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · May 9, 2025
10 Communication Services Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · May 9, 2025
10 Information Technology Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · May 9, 2025
Alphabet’s Google Reaches $50M Settlement Over Claims of Systemic Racial Discrimination Against Black Employeesstocktwits.com
Google’s back-to-back discrimination cases have pushed Alphabet’s settlement total to $78 million in just two months.
Via Stocktwits · May 9, 2025
New FDA Leadership Could Raise The Bar For Drug Approvalsbenzinga.com
A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.
Via Benzinga · May 9, 2025
Trade Tensions Push Dow Down Triple Digitstalkmarkets.com
Trade talks are in focus, ahead of negotiations between U.S. and Chinese officials, which will begin in Switzerland this weekend.
Via Talk Markets · May 9, 2025
Lyft Is Executing Well But Analysts Caution About Uber And Waymo Competitionbenzinga.com
Lyft stock rises on $1.45B revenue, $750M buyback plan. Needham reiterates hold, Goldman Sachs upgrades to buy with PT of $20. Strong growth despite competition.
Via Benzinga · May 9, 2025